Chris Rubino
Overview
Explore the profile of Chris Rubino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
94
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lepak A, VanScoy B, Rubino C, Ambrose P, Andes D
Antimicrob Agents Chemother
. 2024 Feb;
68(3):e0163123.
PMID: 38319077
SF001 is a next-generation polyene antifungal drug in development, designed to have increased specificity to fungal ergosterol, which is absent in humans, and decreased binding to cholesterol. SF001 demonstrates long-acting,...
2.
Schmidt P, Narayan K, Li Y, Kaku C, Brown M, Champney E, et al.
medRxiv
. 2022 Oct;
PMID: 36299436
Multiple studies of vaccinated and convalescent cohorts have demonstrated that serum neutralizing antibody (nAb) titers correlate with protection against COVID-19. However, the induction of multiple layers of immunity following SARS-CoV-2...
3.
Dunne M, Puttagunta S, Sprenger C, Rubino C, Van Wart S, Baldassarre J
Antimicrob Agents Chemother
. 2015 Jan;
59(4):1849-55.
PMID: 25561338
Dalbavancin is an intravenous lipoglycopeptide with activity against Gram-positive pathogens and an MIC90 for Staphylococcus aureus of 0.06 μg/ml. With a terminal half-life of >14 days, dosing regimens with infrequent...